Clinical trial · Interventional
Medical Consortium for Screening Upper Gastrointestinal Cancers With Magnetically Controlled Capsule Gastroscopy
NCT04032353CI-TRIAL-00039738unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of our study was to demonstrate the efficacy and feasibility of the medical consortium for screening upper gastrointestinal cancers with magnetically controlled capsule gastroscopy.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer of Esophagus | Malignant Esophageal Neoplasm | ALIAS | 0.90 |
| Cancer of Stomach | Malignant Gastric Neoplasm | ALIAS | 0.90 |
| Capsule Endoscopy | — | UNRESOLVED | — |
| Health Policy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Medical Consortium | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Medical Consortium
- description
- subjects involved in medical consortium for screening upper gastrointestinal canccers(MCSC)
- interventionNames
- Other: Medical Consortium
Primary outcomes (1)
- measure
- the incidence of upper gastrointestinal cancers, including gastric cancer and esophageal cancer.
- timeFrame
- 12 months
Secondary outcomes (1)
- measure
- tthe focal lesions of upper gastrointestinal tract
- timeFrame
- 12 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * asymptomatic subjects undergong magnetically controlled capsule gastroscopy for health checkup in medical consotium; * subjects able to give informed consent Exclusion Criteria: * suspected or known intestinal stenosis, obstruction, or fistula; * inoperability of refusal to accept any abdominal surgery; * dysphagia or gastric paralysis; * previous history of gastrointestinal disease; * with pacemaker, implanted-cardiac defibrillator or other implanted electromedical devices; * need for standard magnetic resonance imaging examination within seven days after swallowing the MCCG, unless the capsule is confirmed to have been excreted; * other factors that are not suitable for inclusion evaluated by medical stuff
References
Publications (0)
Data not yet available
No reference posted for this study.